Low-frequency electromyostimulation and chronic heart failure

Détails

ID Serval
serval:BIB_14E8890FAE17
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Low-frequency electromyostimulation and chronic heart failure
Périodique
Ann Readapt Med Phys
Auteur⸱e⸱s
Casillas J. M., Gremeaux V., Labrunee M., Troigros O., Laurent Y., Deley G., Eicher J. C.
ISSN
0168-6054 (Print)
ISSN-L
0168-6054
Statut éditorial
Publié
Date de publication
07/2008
Volume
51
Numéro
6
Pages
461-72
Langue
anglais
Notes
Casillas, J-M
Gremeaux, V
Labrunee, M
Troigros, O
Laurent, Y
Deley, G
Eicher, J-C
eng
fre
Netherlands
Ann Readapt Med Phys. 2008 Jul;51(6):461-72. doi: 10.1016/j.annrmp.2008.04.006. Epub 2008 May 21.
Résumé
Low-frequency electromyostimulation (EMS) acts on the skeletal muscle abnormalities that aggravate intolerance to effort in patients with chronic heart failure (CHF). It improves the oxidative capacity of muscles and thus enhances aerobic performance and physical capacity to almost the same degree, as does conventional physical training. No local or hemodynamic intolerance has been reported, even in cases of severe CHF. However, the presence of a pacemaker is one of the relative contra-indications (prior evaluation of tolerance is required), while that of an implanted defibrillator is one of the absolute contra-indications. EMS is an alternative to physical effort training when the latter is impossible due to a high degree of deconditioning or because there is a contra-indication, which may be temporary, due to the risk of acute decompensation and/or rhythm troubles. EMS can also be used in patients waiting for a heart transplant or in CHF patients who are unwilling to engage in physical activities. As EMS is not expensive and easy to set up, its use is likely to develop in the future.
Mots-clé
Chronic Disease, Electric Stimulation Therapy/*methods, Heart Failure/complications/physiopathology/*therapy, Humans
Pubmed
Création de la notice
26/11/2019 12:35
Dernière modification de la notice
06/05/2020 6:26
Données d'usage